# Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine

> **NCT01435941** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 11249 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Non-steroidal anti-inflammatory drug (NSAID)
- **DRUG:** Triptan

## Key facts

- **NCT ID:** NCT01435941
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 11249 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435941, "Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01435941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*